Biblio
Export 497 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is Y [Clear All Filters]
“A Fragment of S38AA is a Novel Plasma Biomarker of Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 4, pp. 1163-1174, 2019.
, “Gut Microbiota Alteration and Its Time Course in a Tauopathy Mouse Model.”, J Alzheimers Dis, vol. 70, no. 2, pp. 399-412, 2019.
, “Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice.”, J Alzheimers Dis, vol. 68, no. 2, pp. 809-837, 2019.
, “Influx of Tau and Amyloid-β Proteins into the Blood During Hemodialysis as a Therapeutic Extracorporeal Blood Amyloid-β Removal System for Alzheimer's Disease.”, J Alzheimers Dis, vol. 69, no. 3, pp. 687-707, 2019.
, “Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers.”, J Alzheimers Dis, vol. 67, no. 3, pp. 911-921, 2019.
, “Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.”, J Alzheimers Dis, vol. 68, no. 1, pp. 357-365, 2019.
, “Neuronal Exosome-Derived Human Tau is Toxic to Recipient Mouse Neurons in vivo.”, J Alzheimers Dis, vol. 67, no. 2, pp. 541-553, 2019.
, “Porphyromonas gingivalis Infection Induces Amyloid-β Accumulation in Monocytes/Macrophages.”, J Alzheimers Dis, vol. 72, no. 2, pp. 479-494, 2019.
, “Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 3, pp. 979-991, 2019.
, “Sirtuin 3 Mediates Tau Deacetylation.”, J Alzheimers Dis, vol. 69, no. 2, pp. 355-362, 2019.
, “Tau and Amyloid-β Pathology in Japanese Forensic Autopsy Series Under 40 Years of Age: Prevalence and Association with APOE Genotype and Suicide Risk.”, J Alzheimers Dis, vol. 72, no. 2, pp. 641-652, 2019.
, “An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults.”, J Alzheimers Dis, vol. 68, no. 3, pp. 1161-1170, 2019.
, “Aggregates of RNA Binding Proteins and ER Chaperones Linked to Exosomes in Granulovacuolar Degeneration of the Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 75, no. 1, pp. 139-156, 2020.
, “Angiotensin II Blood Levels Are Associated with Smaller Hippocampal and Cortical Volumes in Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 75, no. 2, pp. 521-529, 2020.
, “APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset.”, J Alzheimers Dis, vol. 76, no. 1, pp. 97-119, 2020.
, “The Association of Post-Stroke Cognitive Impairment and Gut Microbiota and its Corresponding Metabolites.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1455-1466, 2020.
, “A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1381-1392, 2020.
, “Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.”, J Alzheimers Dis, vol. 78, no. 1, pp. 321-334, 2020.
, “Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 127-138, 2020.
, “Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.”, J Alzheimers Dis, vol. 75, no. 2, pp. 437-450, 2020.
, “COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications.”, J Alzheimers Dis, vol. 77, no. 2, pp. 459-504, 2020.
, “COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications.”, J Alzheimers Dis, vol. 77, no. 2, pp. 459-504, 2020.
, “Generation of Transgenic Cynomolgus Monkeys Overexpressing the Gene for Amyloid-β Precursor Protein.”, J Alzheimers Dis, vol. 75, no. 1, pp. 45-60, 2020.
, “Glucose Fluctuations Are Linked to Disrupted Brain Functional Architecture and Cognitive Impairment.”, J Alzheimers Dis, vol. 74, no. 2, 2020.
, “An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1639-1653, 2020.
,